Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Cleavage of ultralarge multimers of von Willebrand factor by C-terminal-truncated mutants of ADAMTS-13 under flow.
Tao Z
,
Wang Y
,
Choi H
,
Bernardo A
,
Nishio K
,
Sadler JE
,
López JA
,
Dong JF
.
???displayArticle.abstract???
A disintegrin-like and metalloprotease with thrombospondin type 1-motif 13 (ADAMTS-13) cleaves the A2 domain of von Willebrand factor (VWF), converting the ultralarge (UL) and hyperactive VWF multimers freshly released from endothelial cells to smaller and less active forms found in plasma. Recombinant ADAMTS-13 lacking the C-terminal region is active under static conditions, but its functions under flow conditions have not been determined. Here, we show that VWF-cleaving activity measured under flow was preserved in an ADAMTS-13 mutant lacking the second to eighth thrombospondin-1 motifs and the complement components C1r/C1s, Uegf sea urchin fibropellins, and bone morphogenic protein 1 (CUB) domains, but was severely deficient in a mutant that was further truncated to remove the spacer domain. We also show that the mutant lacking the TSP-1 and CUB domains was hyperactive under flow, suggesting that the C-terminal region may negatively regulate ADAMTS-13 activity. The wild type and the mutant without the spacer were more active in the presence of plasma, raising the possibility of ADAMTS-13 cofactors in plasma.
Dent,
Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit.
1991, Pubmed
Dent,
Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit.
1991,
Pubmed
Dong,
ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions.
2002,
Pubmed
Dong,
Variations among normal individuals in the cleavage of endothelial-derived ultra-large von Willebrand factor under flow.
2004,
Pubmed
Furlan,
Von Willebrand factor: molecular size and functional activity.
1996,
Pubmed
Furlan,
Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis.
1996,
Pubmed
Gao,
Activation of the proteolytic activity of ADAMTS4 (aggrecanase-1) by C-terminal truncation.
2002,
Pubmed
Gerritsen,
Partial amino acid sequence of purified von Willebrand factor-cleaving protease.
2001,
Pubmed
Kashiwagi,
Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing.
2004,
Pubmed
Levy,
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.
2001,
Pubmed
Moake,
Thrombotic thrombocytopenic purpura: the systemic clumping "plague".
2002,
Pubmed
Moake,
Thrombotic microangiopathies.
2002,
Pubmed
Moake,
Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura.
1982,
Pubmed
Nishio,
Binding of platelet glycoprotein Ibalpha to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13.
2004,
Pubmed
Padilla,
P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface.
2004,
Pubmed
Soejima,
ADAMTS-13 cysteine-rich/spacer domains are functionally essential for von Willebrand factor cleavage.
2003,
Pubmed
Zheng,
Cleavage of von Willebrand factor requires the spacer domain of the metalloprotease ADAMTS13.
2003,
Pubmed
